nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2C8—Omeprazole—Barrett's esophagus	0.169	0.332	CbGbCtD
Paroxetine—CYP2C9—Omeprazole—Barrett's esophagus	0.118	0.232	CbGbCtD
Paroxetine—ABCB1—Omeprazole—Barrett's esophagus	0.114	0.225	CbGbCtD
Paroxetine—CYP2D6—Omeprazole—Barrett's esophagus	0.107	0.212	CbGbCtD
Paroxetine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—Barrett's esophagus	0.0068	0.125	CbGpPWpGaD
Paroxetine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00543	0.0996	CbGpPWpGaD
Paroxetine—TACR1—smooth muscle tissue—Barrett's esophagus	0.0014	0.16	CbGeAlD
Paroxetine—CHRM3—exocrine gland—Barrett's esophagus	0.00138	0.157	CbGeAlD
Paroxetine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00137	0.0252	CbGpPWpGaD
Paroxetine—TACR1—digestive system—Barrett's esophagus	0.00111	0.126	CbGeAlD
Paroxetine—CHRM5—epithelium—Barrett's esophagus	0.00107	0.122	CbGeAlD
Paroxetine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00107	0.0196	CbGpPWpGaD
Paroxetine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00107	0.0196	CbGpPWpGaD
Paroxetine—Increased appetite—Esomeprazole—Barrett's esophagus	0.00102	0.00239	CcSEcCtD
Paroxetine—Increased appetite—Omeprazole—Barrett's esophagus	0.00102	0.00239	CcSEcCtD
Paroxetine—Visual disturbance—Esomeprazole—Barrett's esophagus	0.00101	0.00237	CcSEcCtD
Paroxetine—Visual disturbance—Omeprazole—Barrett's esophagus	0.00101	0.00237	CcSEcCtD
Paroxetine—Thirst—Omeprazole—Barrett's esophagus	0.00101	0.00236	CcSEcCtD
Paroxetine—Renal impairment—Omeprazole—Barrett's esophagus	0.00101	0.00236	CcSEcCtD
Paroxetine—Renal impairment—Esomeprazole—Barrett's esophagus	0.00101	0.00236	CcSEcCtD
Paroxetine—Thirst—Esomeprazole—Barrett's esophagus	0.00101	0.00236	CcSEcCtD
Paroxetine—Purpura—Omeprazole—Barrett's esophagus	0.000998	0.00233	CcSEcCtD
Paroxetine—Purpura—Esomeprazole—Barrett's esophagus	0.000998	0.00233	CcSEcCtD
Paroxetine—Arthritis—Esomeprazole—Barrett's esophagus	0.000989	0.00231	CcSEcCtD
Paroxetine—Arthritis—Omeprazole—Barrett's esophagus	0.000989	0.00231	CcSEcCtD
Paroxetine—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.000985	0.0023	CcSEcCtD
Paroxetine—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.000985	0.0023	CcSEcCtD
Paroxetine—TACR1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000968	0.0177	CbGpPWpGaD
Paroxetine—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.000966	0.00225	CcSEcCtD
Paroxetine—Hyponatraemia—Omeprazole—Barrett's esophagus	0.000966	0.00225	CcSEcCtD
Paroxetine—Osteoarthritis—Omeprazole—Barrett's esophagus	0.000962	0.00224	CcSEcCtD
Paroxetine—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000962	0.00224	CcSEcCtD
Paroxetine—Diplopia—Esomeprazole—Barrett's esophagus	0.000962	0.00224	CcSEcCtD
Paroxetine—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000962	0.00224	CcSEcCtD
Paroxetine—Diplopia—Omeprazole—Barrett's esophagus	0.000962	0.00224	CcSEcCtD
Paroxetine—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.000962	0.00224	CcSEcCtD
Paroxetine—Migraine—Omeprazole—Barrett's esophagus	0.000947	0.00221	CcSEcCtD
Paroxetine—Migraine—Esomeprazole—Barrett's esophagus	0.000947	0.00221	CcSEcCtD
Paroxetine—Face oedema—Esomeprazole—Barrett's esophagus	0.000928	0.00216	CcSEcCtD
Paroxetine—Face oedema—Omeprazole—Barrett's esophagus	0.000928	0.00216	CcSEcCtD
Paroxetine—Dry skin—Omeprazole—Barrett's esophagus	0.000881	0.00205	CcSEcCtD
Paroxetine—Dry skin—Esomeprazole—Barrett's esophagus	0.000881	0.00205	CcSEcCtD
Paroxetine—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000877	0.0161	CbGpPWpGaD
Paroxetine—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000875	0.00204	CcSEcCtD
Paroxetine—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000875	0.00204	CcSEcCtD
Paroxetine—Breast disorder—Omeprazole—Barrett's esophagus	0.000869	0.00203	CcSEcCtD
Paroxetine—Breast disorder—Esomeprazole—Barrett's esophagus	0.000869	0.00203	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000866	0.00202	CcSEcCtD
Paroxetine—Cramp muscle—Omeprazole—Barrett's esophagus	0.000866	0.00202	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000866	0.00202	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000866	0.00202	CcSEcCtD
Paroxetine—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000866	0.00202	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000866	0.00202	CcSEcCtD
Paroxetine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000866	0.0159	CbGpPWpGaD
Paroxetine—Gastritis—Omeprazole—Barrett's esophagus	0.000851	0.00198	CcSEcCtD
Paroxetine—Gastritis—Esomeprazole—Barrett's esophagus	0.000851	0.00198	CcSEcCtD
Paroxetine—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000848	0.00198	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000848	0.00198	CcSEcCtD
Paroxetine—Muscular weakness—Omeprazole—Barrett's esophagus	0.000848	0.00198	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000848	0.00198	CcSEcCtD
Paroxetine—Influenza—Esomeprazole—Barrett's esophagus	0.000831	0.00194	CcSEcCtD
Paroxetine—Dysphagia—Esomeprazole—Barrett's esophagus	0.000831	0.00194	CcSEcCtD
Paroxetine—Influenza—Omeprazole—Barrett's esophagus	0.000831	0.00194	CcSEcCtD
Paroxetine—Asthma—Omeprazole—Barrett's esophagus	0.000831	0.00194	CcSEcCtD
Paroxetine—Dysphagia—Omeprazole—Barrett's esophagus	0.000831	0.00194	CcSEcCtD
Paroxetine—Asthma—Esomeprazole—Barrett's esophagus	0.000831	0.00194	CcSEcCtD
Paroxetine—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000815	0.0019	CcSEcCtD
Paroxetine—Pancreatitis—Omeprazole—Barrett's esophagus	0.000815	0.0019	CcSEcCtD
Paroxetine—Sweating increased—Esomeprazole—Barrett's esophagus	0.00081	0.00189	CcSEcCtD
Paroxetine—Angina pectoris—Omeprazole—Barrett's esophagus	0.00081	0.00189	CcSEcCtD
Paroxetine—Sweating increased—Omeprazole—Barrett's esophagus	0.00081	0.00189	CcSEcCtD
Paroxetine—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00081	0.00189	CcSEcCtD
Paroxetine—Pancytopenia—Omeprazole—Barrett's esophagus	0.000789	0.00184	CcSEcCtD
Paroxetine—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000789	0.00184	CcSEcCtD
Paroxetine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000789	0.0145	CbGpPWpGaD
Paroxetine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000789	0.0145	CbGpPWpGaD
Paroxetine—Dysuria—Omeprazole—Barrett's esophagus	0.000777	0.00181	CcSEcCtD
Paroxetine—Dysuria—Esomeprazole—Barrett's esophagus	0.000777	0.00181	CcSEcCtD
Paroxetine—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000768	0.00179	CcSEcCtD
Paroxetine—Pollakiuria—Omeprazole—Barrett's esophagus	0.000768	0.00179	CcSEcCtD
Paroxetine—TACR1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000767	0.0141	CbGpPWpGaD
Paroxetine—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000765	0.00178	CcSEcCtD
Paroxetine—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000765	0.00178	CcSEcCtD
Paroxetine—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000759	0.00177	CcSEcCtD
Paroxetine—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000759	0.00177	CcSEcCtD
Paroxetine—Weight increased—Esomeprazole—Barrett's esophagus	0.000756	0.00176	CcSEcCtD
Paroxetine—Weight increased—Omeprazole—Barrett's esophagus	0.000756	0.00176	CcSEcCtD
Paroxetine—Weight decreased—Omeprazole—Barrett's esophagus	0.000752	0.00175	CcSEcCtD
Paroxetine—Weight decreased—Esomeprazole—Barrett's esophagus	0.000752	0.00175	CcSEcCtD
Paroxetine—Depression—Esomeprazole—Barrett's esophagus	0.000739	0.00172	CcSEcCtD
Paroxetine—Depression—Omeprazole—Barrett's esophagus	0.000739	0.00172	CcSEcCtD
Paroxetine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000737	0.0135	CbGpPWpGaD
Paroxetine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000737	0.0135	CbGpPWpGaD
Paroxetine—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000735	0.00171	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000735	0.00171	CcSEcCtD
Paroxetine—SLC6A4—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000725	0.0133	CbGpPWpGaD
Paroxetine—Stomatitis—Esomeprazole—Barrett's esophagus	0.000722	0.00168	CcSEcCtD
Paroxetine—Jaundice—Esomeprazole—Barrett's esophagus	0.000722	0.00168	CcSEcCtD
Paroxetine—Stomatitis—Omeprazole—Barrett's esophagus	0.000722	0.00168	CcSEcCtD
Paroxetine—Jaundice—Omeprazole—Barrett's esophagus	0.000722	0.00168	CcSEcCtD
Paroxetine—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00072	0.00168	CcSEcCtD
Paroxetine—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00072	0.00168	CcSEcCtD
Paroxetine—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00072	0.00168	CcSEcCtD
Paroxetine—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00072	0.00168	CcSEcCtD
Paroxetine—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000714	0.0131	CbGpPWpGaD
Paroxetine—Haematuria—Esomeprazole—Barrett's esophagus	0.000707	0.00165	CcSEcCtD
Paroxetine—Haematuria—Omeprazole—Barrett's esophagus	0.000707	0.00165	CcSEcCtD
Paroxetine—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000701	0.00163	CcSEcCtD
Paroxetine—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000701	0.00163	CcSEcCtD
Paroxetine—Epistaxis—Esomeprazole—Barrett's esophagus	0.000699	0.00163	CcSEcCtD
Paroxetine—Epistaxis—Omeprazole—Barrett's esophagus	0.000699	0.00163	CcSEcCtD
Paroxetine—Sinusitis—Esomeprazole—Barrett's esophagus	0.000695	0.00162	CcSEcCtD
Paroxetine—Sinusitis—Omeprazole—Barrett's esophagus	0.000695	0.00162	CcSEcCtD
Paroxetine—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000692	0.00161	CcSEcCtD
Paroxetine—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000692	0.00161	CcSEcCtD
Paroxetine—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000679	0.0124	CbGpPWpGaD
Paroxetine—Bradycardia—Omeprazole—Barrett's esophagus	0.000677	0.00158	CcSEcCtD
Paroxetine—Bradycardia—Esomeprazole—Barrett's esophagus	0.000677	0.00158	CcSEcCtD
Paroxetine—CYP2B6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00067	0.0123	CbGpPWpGaD
Paroxetine—Rhinitis—Esomeprazole—Barrett's esophagus	0.000667	0.00155	CcSEcCtD
Paroxetine—Rhinitis—Omeprazole—Barrett's esophagus	0.000667	0.00155	CcSEcCtD
Paroxetine—Hepatitis—Omeprazole—Barrett's esophagus	0.000665	0.00155	CcSEcCtD
Paroxetine—Hepatitis—Esomeprazole—Barrett's esophagus	0.000665	0.00155	CcSEcCtD
Paroxetine—Hallucination—Omeprazole—Barrett's esophagus	0.000662	0.00154	CcSEcCtD
Paroxetine—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000662	0.00154	CcSEcCtD
Paroxetine—Hallucination—Esomeprazole—Barrett's esophagus	0.000662	0.00154	CcSEcCtD
Paroxetine—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000662	0.00154	CcSEcCtD
Paroxetine—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00066	0.00154	CcSEcCtD
Paroxetine—Pharyngitis—Omeprazole—Barrett's esophagus	0.00066	0.00154	CcSEcCtD
Paroxetine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000655	0.00153	CcSEcCtD
Paroxetine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000655	0.00153	CcSEcCtD
Paroxetine—TACR1—Peptide ligand-binding receptors—SST—Barrett's esophagus	0.000655	0.012	CbGpPWpGaD
Paroxetine—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000654	0.00152	CcSEcCtD
Paroxetine—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000654	0.00152	CcSEcCtD
Paroxetine—Visual impairment—Esomeprazole—Barrett's esophagus	0.000641	0.00149	CcSEcCtD
Paroxetine—Visual impairment—Omeprazole—Barrett's esophagus	0.000641	0.00149	CcSEcCtD
Paroxetine—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000629	0.00147	CcSEcCtD
Paroxetine—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000629	0.00147	CcSEcCtD
Paroxetine—Eye disorder—Esomeprazole—Barrett's esophagus	0.000622	0.00145	CcSEcCtD
Paroxetine—Eye disorder—Omeprazole—Barrett's esophagus	0.000622	0.00145	CcSEcCtD
Paroxetine—Tinnitus—Esomeprazole—Barrett's esophagus	0.00062	0.00145	CcSEcCtD
Paroxetine—Tinnitus—Omeprazole—Barrett's esophagus	0.00062	0.00145	CcSEcCtD
Paroxetine—Flushing—Omeprazole—Barrett's esophagus	0.000617	0.00144	CcSEcCtD
Paroxetine—Flushing—Esomeprazole—Barrett's esophagus	0.000617	0.00144	CcSEcCtD
Paroxetine—Immune system disorder—Omeprazole—Barrett's esophagus	0.000601	0.0014	CcSEcCtD
Paroxetine—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000601	0.0014	CcSEcCtD
Paroxetine—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.0006	0.0014	CcSEcCtD
Paroxetine—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.0006	0.0014	CcSEcCtD
Paroxetine—Chills—Esomeprazole—Barrett's esophagus	0.000597	0.00139	CcSEcCtD
Paroxetine—Chills—Omeprazole—Barrett's esophagus	0.000597	0.00139	CcSEcCtD
Paroxetine—Alopecia—Omeprazole—Barrett's esophagus	0.000588	0.00137	CcSEcCtD
Paroxetine—Alopecia—Esomeprazole—Barrett's esophagus	0.000588	0.00137	CcSEcCtD
Paroxetine—Mental disorder—Omeprazole—Barrett's esophagus	0.000583	0.00136	CcSEcCtD
Paroxetine—Mental disorder—Esomeprazole—Barrett's esophagus	0.000583	0.00136	CcSEcCtD
Paroxetine—Malnutrition—Omeprazole—Barrett's esophagus	0.000579	0.00135	CcSEcCtD
Paroxetine—Malnutrition—Esomeprazole—Barrett's esophagus	0.000579	0.00135	CcSEcCtD
Paroxetine—CHRM3—smooth muscle tissue—Barrett's esophagus	0.000577	0.0657	CbGeAlD
Paroxetine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000575	0.0105	CbGpPWpGaD
Paroxetine—Flatulence—Omeprazole—Barrett's esophagus	0.000571	0.00133	CcSEcCtD
Paroxetine—Flatulence—Esomeprazole—Barrett's esophagus	0.000571	0.00133	CcSEcCtD
Paroxetine—Tension—Esomeprazole—Barrett's esophagus	0.000568	0.00132	CcSEcCtD
Paroxetine—Tension—Omeprazole—Barrett's esophagus	0.000568	0.00132	CcSEcCtD
Paroxetine—Dysgeusia—Omeprazole—Barrett's esophagus	0.000567	0.00132	CcSEcCtD
Paroxetine—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000567	0.00132	CcSEcCtD
Paroxetine—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000567	0.0104	CbGpPWpGaD
Paroxetine—Nervousness—Omeprazole—Barrett's esophagus	0.000562	0.00131	CcSEcCtD
Paroxetine—Nervousness—Esomeprazole—Barrett's esophagus	0.000562	0.00131	CcSEcCtD
Paroxetine—Back pain—Omeprazole—Barrett's esophagus	0.00056	0.00131	CcSEcCtD
Paroxetine—Back pain—Esomeprazole—Barrett's esophagus	0.00056	0.00131	CcSEcCtD
Paroxetine—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000557	0.0013	CcSEcCtD
Paroxetine—Muscle spasms—Omeprazole—Barrett's esophagus	0.000557	0.0013	CcSEcCtD
Paroxetine—CYP2B6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00055	0.0101	CbGpPWpGaD
Paroxetine—Vision blurred—Omeprazole—Barrett's esophagus	0.000546	0.00127	CcSEcCtD
Paroxetine—Vision blurred—Esomeprazole—Barrett's esophagus	0.000546	0.00127	CcSEcCtD
Paroxetine—Tremor—Omeprazole—Barrett's esophagus	0.000543	0.00126	CcSEcCtD
Paroxetine—Tremor—Esomeprazole—Barrett's esophagus	0.000543	0.00126	CcSEcCtD
Paroxetine—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000537	0.00125	CcSEcCtD
Paroxetine—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000537	0.00125	CcSEcCtD
Paroxetine—Anaemia—Omeprazole—Barrett's esophagus	0.000535	0.00125	CcSEcCtD
Paroxetine—Anaemia—Esomeprazole—Barrett's esophagus	0.000535	0.00125	CcSEcCtD
Paroxetine—Agitation—Omeprazole—Barrett's esophagus	0.000532	0.00124	CcSEcCtD
Paroxetine—Agitation—Esomeprazole—Barrett's esophagus	0.000532	0.00124	CcSEcCtD
Paroxetine—Angioedema—Esomeprazole—Barrett's esophagus	0.000529	0.00123	CcSEcCtD
Paroxetine—Angioedema—Omeprazole—Barrett's esophagus	0.000529	0.00123	CcSEcCtD
Paroxetine—Malaise—Omeprazole—Barrett's esophagus	0.000522	0.00122	CcSEcCtD
Paroxetine—Malaise—Esomeprazole—Barrett's esophagus	0.000522	0.00122	CcSEcCtD
Paroxetine—Vertigo—Omeprazole—Barrett's esophagus	0.00052	0.00121	CcSEcCtD
Paroxetine—Vertigo—Esomeprazole—Barrett's esophagus	0.00052	0.00121	CcSEcCtD
Paroxetine—Leukopenia—Esomeprazole—Barrett's esophagus	0.000518	0.00121	CcSEcCtD
Paroxetine—Leukopenia—Omeprazole—Barrett's esophagus	0.000518	0.00121	CcSEcCtD
Paroxetine—Palpitations—Omeprazole—Barrett's esophagus	0.000512	0.00119	CcSEcCtD
Paroxetine—Palpitations—Esomeprazole—Barrett's esophagus	0.000512	0.00119	CcSEcCtD
Paroxetine—SLC6A4—digestive system—Barrett's esophagus	0.000511	0.0581	CbGeAlD
Paroxetine—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000507	0.0093	CbGpPWpGaD
Paroxetine—Cough—Omeprazole—Barrett's esophagus	0.000505	0.00118	CcSEcCtD
Paroxetine—Cough—Esomeprazole—Barrett's esophagus	0.000505	0.00118	CcSEcCtD
Paroxetine—Hypertension—Omeprazole—Barrett's esophagus	0.0005	0.00117	CcSEcCtD
Paroxetine—Hypertension—Esomeprazole—Barrett's esophagus	0.0005	0.00117	CcSEcCtD
Paroxetine—Arthralgia—Omeprazole—Barrett's esophagus	0.000493	0.00115	CcSEcCtD
Paroxetine—Myalgia—Esomeprazole—Barrett's esophagus	0.000493	0.00115	CcSEcCtD
Paroxetine—Chest pain—Esomeprazole—Barrett's esophagus	0.000493	0.00115	CcSEcCtD
Paroxetine—Chest pain—Omeprazole—Barrett's esophagus	0.000493	0.00115	CcSEcCtD
Paroxetine—Myalgia—Omeprazole—Barrett's esophagus	0.000493	0.00115	CcSEcCtD
Paroxetine—Arthralgia—Esomeprazole—Barrett's esophagus	0.000493	0.00115	CcSEcCtD
Paroxetine—Anxiety—Omeprazole—Barrett's esophagus	0.000491	0.00115	CcSEcCtD
Paroxetine—Anxiety—Esomeprazole—Barrett's esophagus	0.000491	0.00115	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00049	0.00114	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00049	0.00114	CcSEcCtD
Paroxetine—Discomfort—Esomeprazole—Barrett's esophagus	0.000487	0.00114	CcSEcCtD
Paroxetine—Discomfort—Omeprazole—Barrett's esophagus	0.000487	0.00114	CcSEcCtD
Paroxetine—Dry mouth—Omeprazole—Barrett's esophagus	0.000482	0.00112	CcSEcCtD
Paroxetine—Dry mouth—Esomeprazole—Barrett's esophagus	0.000482	0.00112	CcSEcCtD
Paroxetine—Confusional state—Esomeprazole—Barrett's esophagus	0.000477	0.00111	CcSEcCtD
Paroxetine—Confusional state—Omeprazole—Barrett's esophagus	0.000477	0.00111	CcSEcCtD
Paroxetine—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000473	0.0011	CcSEcCtD
Paroxetine—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000473	0.0011	CcSEcCtD
Paroxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000472	0.00865	CbGpPWpGaD
Paroxetine—Infection—Esomeprazole—Barrett's esophagus	0.00047	0.00109	CcSEcCtD
Paroxetine—Infection—Omeprazole—Barrett's esophagus	0.00047	0.00109	CcSEcCtD
Paroxetine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000468	0.00857	CbGpPWpGaD
Paroxetine—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000466	0.00854	CbGpPWpGaD
Paroxetine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000466	0.00854	CbGpPWpGaD
Paroxetine—Shock—Esomeprazole—Barrett's esophagus	0.000465	0.00108	CcSEcCtD
Paroxetine—Shock—Omeprazole—Barrett's esophagus	0.000465	0.00108	CcSEcCtD
Paroxetine—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000464	0.00108	CcSEcCtD
Paroxetine—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000464	0.00108	CcSEcCtD
Paroxetine—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000463	0.00108	CcSEcCtD
Paroxetine—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000463	0.00108	CcSEcCtD
Paroxetine—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000462	0.00846	CbGpPWpGaD
Paroxetine—Tachycardia—Omeprazole—Barrett's esophagus	0.000461	0.00108	CcSEcCtD
Paroxetine—Tachycardia—Esomeprazole—Barrett's esophagus	0.000461	0.00108	CcSEcCtD
Paroxetine—Skin disorder—Omeprazole—Barrett's esophagus	0.000459	0.00107	CcSEcCtD
Paroxetine—Skin disorder—Esomeprazole—Barrett's esophagus	0.000459	0.00107	CcSEcCtD
Paroxetine—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000457	0.00106	CcSEcCtD
Paroxetine—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000457	0.00106	CcSEcCtD
Paroxetine—CHRM3—digestive system—Barrett's esophagus	0.000456	0.0518	CbGeAlD
Paroxetine—TACR1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000439	0.00806	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000434	0.00796	CbGpPWpGaD
Paroxetine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000431	0.001	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000431	0.001	CcSEcCtD
Paroxetine—Insomnia—Omeprazole—Barrett's esophagus	0.000427	0.000996	CcSEcCtD
Paroxetine—Insomnia—Esomeprazole—Barrett's esophagus	0.000427	0.000996	CcSEcCtD
Paroxetine—CHRM5—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000426	0.0078	CbGpPWpGaD
Paroxetine—Paraesthesia—Omeprazole—Barrett's esophagus	0.000424	0.000989	CcSEcCtD
Paroxetine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000424	0.000989	CcSEcCtD
Paroxetine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000421	0.000982	CcSEcCtD
Paroxetine—Dyspnoea—Omeprazole—Barrett's esophagus	0.000421	0.000982	CcSEcCtD
Paroxetine—Somnolence—Esomeprazole—Barrett's esophagus	0.00042	0.000979	CcSEcCtD
Paroxetine—Somnolence—Omeprazole—Barrett's esophagus	0.00042	0.000979	CcSEcCtD
Paroxetine—Dyspepsia—Omeprazole—Barrett's esophagus	0.000416	0.00097	CcSEcCtD
Paroxetine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000416	0.00097	CcSEcCtD
Paroxetine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000411	0.000958	CcSEcCtD
Paroxetine—Decreased appetite—Omeprazole—Barrett's esophagus	0.000411	0.000958	CcSEcCtD
Paroxetine—CHRM4—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000409	0.00749	CbGpPWpGaD
Paroxetine—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000408	0.000951	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000408	0.000951	CcSEcCtD
Paroxetine—Fatigue—Omeprazole—Barrett's esophagus	0.000407	0.00095	CcSEcCtD
Paroxetine—Fatigue—Esomeprazole—Barrett's esophagus	0.000407	0.00095	CcSEcCtD
Paroxetine—Constipation—Omeprazole—Barrett's esophagus	0.000404	0.000942	CcSEcCtD
Paroxetine—Pain—Omeprazole—Barrett's esophagus	0.000404	0.000942	CcSEcCtD
Paroxetine—Constipation—Esomeprazole—Barrett's esophagus	0.000404	0.000942	CcSEcCtD
Paroxetine—Pain—Esomeprazole—Barrett's esophagus	0.000404	0.000942	CcSEcCtD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000397	0.00727	CbGpPWpGaD
Paroxetine—CHRM5—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000391	0.00718	CbGpPWpGaD
Paroxetine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000389	0.000908	CcSEcCtD
Paroxetine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000389	0.000908	CcSEcCtD
Paroxetine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000386	0.000901	CcSEcCtD
Paroxetine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000386	0.000901	CcSEcCtD
Paroxetine—TACR1—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000385	0.00706	CbGpPWpGaD
Paroxetine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000382	0.00701	CbGpPWpGaD
Paroxetine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000381	0.00698	CbGpPWpGaD
Paroxetine—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000379	0.00695	CbGpPWpGaD
Paroxetine—Urticaria—Omeprazole—Barrett's esophagus	0.000375	0.000875	CcSEcCtD
Paroxetine—Urticaria—Esomeprazole—Barrett's esophagus	0.000375	0.000875	CcSEcCtD
Paroxetine—Body temperature increased—Omeprazole—Barrett's esophagus	0.000374	0.000871	CcSEcCtD
Paroxetine—Abdominal pain—Omeprazole—Barrett's esophagus	0.000374	0.000871	CcSEcCtD
Paroxetine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000374	0.000871	CcSEcCtD
Paroxetine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000374	0.000871	CcSEcCtD
Paroxetine—TACR1—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000374	0.00685	CbGpPWpGaD
Paroxetine—HTR2A—epithelium—Barrett's esophagus	0.000356	0.0404	CbGeAlD
Paroxetine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000352	0.00645	CbGpPWpGaD
Paroxetine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000348	0.000812	CcSEcCtD
Paroxetine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000348	0.000812	CcSEcCtD
Paroxetine—HTR2A—smooth muscle tissue—Barrett's esophagus	0.000343	0.039	CbGeAlD
Paroxetine—Asthenia—Esomeprazole—Barrett's esophagus	0.000339	0.00079	CcSEcCtD
Paroxetine—Asthenia—Omeprazole—Barrett's esophagus	0.000339	0.00079	CcSEcCtD
Paroxetine—TACR1—GPCR ligand binding—SST—Barrett's esophagus	0.000335	0.00613	CbGpPWpGaD
Paroxetine—Pruritus—Esomeprazole—Barrett's esophagus	0.000334	0.000779	CcSEcCtD
Paroxetine—Pruritus—Omeprazole—Barrett's esophagus	0.000334	0.000779	CcSEcCtD
Paroxetine—CYP2B6—digestive system—Barrett's esophagus	0.000332	0.0377	CbGeAlD
Paroxetine—CYP2C9—digestive system—Barrett's esophagus	0.000328	0.0374	CbGeAlD
Paroxetine—Diarrhoea—Omeprazole—Barrett's esophagus	0.000323	0.000754	CcSEcCtD
Paroxetine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000323	0.000754	CcSEcCtD
Paroxetine—Dizziness—Esomeprazole—Barrett's esophagus	0.000313	0.000728	CcSEcCtD
Paroxetine—Dizziness—Omeprazole—Barrett's esophagus	0.000313	0.000728	CcSEcCtD
Paroxetine—HTR2A—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000301	0.00552	CbGpPWpGaD
Paroxetine—Vomiting—Esomeprazole—Barrett's esophagus	0.000301	0.0007	CcSEcCtD
Paroxetine—Vomiting—Omeprazole—Barrett's esophagus	0.000301	0.0007	CcSEcCtD
Paroxetine—CHRM1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.0003	0.0055	CbGpPWpGaD
Paroxetine—TACR1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000299	0.00548	CbGpPWpGaD
Paroxetine—CHRM3—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000299	0.00548	CbGpPWpGaD
Paroxetine—SLC6A4—NRF2 pathway—HGF—Barrett's esophagus	0.000298	0.00546	CbGpPWpGaD
Paroxetine—Rash—Esomeprazole—Barrett's esophagus	0.000298	0.000695	CcSEcCtD
Paroxetine—Rash—Omeprazole—Barrett's esophagus	0.000298	0.000695	CcSEcCtD
Paroxetine—Dermatitis—Omeprazole—Barrett's esophagus	0.000298	0.000694	CcSEcCtD
Paroxetine—Dermatitis—Esomeprazole—Barrett's esophagus	0.000298	0.000694	CcSEcCtD
Paroxetine—Headache—Esomeprazole—Barrett's esophagus	0.000296	0.00069	CcSEcCtD
Paroxetine—Headache—Omeprazole—Barrett's esophagus	0.000296	0.00069	CcSEcCtD
Paroxetine—CYP2B6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000292	0.00536	CbGpPWpGaD
Paroxetine—CYP2B6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000288	0.00529	CbGpPWpGaD
Paroxetine—Nausea—Omeprazole—Barrett's esophagus	0.000281	0.000654	CcSEcCtD
Paroxetine—Nausea—Esomeprazole—Barrett's esophagus	0.000281	0.000654	CcSEcCtD
Paroxetine—TACR1—GPCR downstream signaling—GAST—Barrett's esophagus	0.000276	0.00506	CbGpPWpGaD
Paroxetine—CHRM1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000276	0.00505	CbGpPWpGaD
Paroxetine—CHRM3—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000275	0.00504	CbGpPWpGaD
Paroxetine—CHRM2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000272	0.00499	CbGpPWpGaD
Paroxetine—HTR2A—digestive system—Barrett's esophagus	0.000271	0.0308	CbGeAlD
Paroxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.00027	0.00494	CbGpPWpGaD
Paroxetine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000268	0.00491	CbGpPWpGaD
Paroxetine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000267	0.0049	CbGpPWpGaD
Paroxetine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000259	0.00476	CbGpPWpGaD
Paroxetine—SLC6A2—NRF2 pathway—HGF—Barrett's esophagus	0.000256	0.0047	CbGpPWpGaD
Paroxetine—TACR1—Peptide ligand-binding receptors—CXCL8—Barrett's esophagus	0.000255	0.00468	CbGpPWpGaD
Paroxetine—CHRM4—G alpha (i) signalling events—SST—Barrett's esophagus	0.000254	0.00465	CbGpPWpGaD
Paroxetine—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000254	0.00465	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—GAST—Barrett's esophagus	0.000251	0.00459	CbGpPWpGaD
Paroxetine—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000247	0.00454	CbGpPWpGaD
Paroxetine—CYP2D6—digestive system—Barrett's esophagus	0.000246	0.028	CbGeAlD
Paroxetine—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000244	0.00447	CbGpPWpGaD
Paroxetine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000242	0.00444	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000239	0.00438	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000234	0.0043	CbGpPWpGaD
Paroxetine—ABCB1—epithelium—Barrett's esophagus	0.000233	0.0265	CbGeAlD
Paroxetine—TACR1—Spinal Cord Injury—TP53—Barrett's esophagus	0.000229	0.0042	CbGpPWpGaD
Paroxetine—SLC6A3—NRF2 pathway—HGF—Barrett's esophagus	0.000227	0.00416	CbGpPWpGaD
Paroxetine—SLC6A3—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000225	0.00412	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.00021	0.00385	CbGpPWpGaD
Paroxetine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000203	0.00372	CbGpPWpGaD
Paroxetine—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000202	0.0037	CbGpPWpGaD
Paroxetine—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000201	0.00369	CbGpPWpGaD
Paroxetine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.0002	0.00367	CbGpPWpGaD
Paroxetine—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000199	0.00364	CbGpPWpGaD
Paroxetine—CHRM4—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000193	0.00354	CbGpPWpGaD
Paroxetine—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000193	0.00354	CbGpPWpGaD
Paroxetine—TACR1—GPCR downstream signaling—SST—Barrett's esophagus	0.000189	0.00347	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000186	0.00341	CbGpPWpGaD
Paroxetine—CHRM5—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000185	0.00339	CbGpPWpGaD
Paroxetine—ABCB1—digestive system—Barrett's esophagus	0.000177	0.0202	CbGeAlD
Paroxetine—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000172	0.00316	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—SST—Barrett's esophagus	0.000172	0.00315	CbGpPWpGaD
Paroxetine—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	0.000171	0.00314	CbGpPWpGaD
Paroxetine—CHRM2—G alpha (i) signalling events—SST—Barrett's esophagus	0.000169	0.0031	CbGpPWpGaD
Paroxetine—SLC6A4—Circadian rythm related genes—PPARG—Barrett's esophagus	0.000165	0.00303	CbGpPWpGaD
Paroxetine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000155	0.00283	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—SST—Barrett's esophagus	0.000154	0.00282	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—GAST—Barrett's esophagus	0.000148	0.00271	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—SST—Barrett's esophagus	0.000147	0.0027	CbGpPWpGaD
Paroxetine—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00014	0.00257	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000137	0.00251	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000136	0.00249	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000136	0.00249	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000134	0.00246	CbGpPWpGaD
Paroxetine—TACR1—GPCR ligand binding—CXCL8—Barrett's esophagus	0.00013	0.00239	CbGpPWpGaD
Paroxetine—CHRM1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.00013	0.00239	CbGpPWpGaD
Paroxetine—CHRM3—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.00013	0.00238	CbGpPWpGaD
Paroxetine—SLC6A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000129	0.00236	CbGpPWpGaD
Paroxetine—CHRM2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000129	0.00236	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—GAST—Barrett's esophagus	0.000127	0.00232	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000125	0.0023	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—GAST—Barrett's esophagus	0.000121	0.00222	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—GAST—Barrett's esophagus	0.000115	0.00211	CbGpPWpGaD
Paroxetine—SLC6A3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000114	0.00209	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—GAST—Barrett's esophagus	0.00011	0.00202	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—SST—Barrett's esophagus	0.000104	0.00191	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—SST—Barrett's esophagus	0.000104	0.0019	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—SST—Barrett's esophagus	0.000103	0.00189	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—SST—Barrett's esophagus	0.000102	0.00187	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000102	0.00187	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—SST—Barrett's esophagus	0.000101	0.00186	CbGpPWpGaD
Paroxetine—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000101	0.00185	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—PPARG—Barrett's esophagus	9.9e-05	0.00182	CbGpPWpGaD
Paroxetine—CHRM4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	9.89e-05	0.00181	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	9.3e-05	0.00171	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	9.26e-05	0.0017	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	9.13e-05	0.00167	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—SST—Barrett's esophagus	8.68e-05	0.00159	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—GAST—Barrett's esophagus	8.59e-05	0.00157	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—GAST—Barrett's esophagus	8.54e-05	0.00157	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—GAST—Barrett's esophagus	8.52e-05	0.00156	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—GAST—Barrett's esophagus	8.43e-05	0.00155	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—SST—Barrett's esophagus	8.32e-05	0.00152	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—SST—Barrett's esophagus	7.89e-05	0.00145	CbGpPWpGaD
Paroxetine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	7.86e-05	0.00144	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—GAST—Barrett's esophagus	7.8e-05	0.00143	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—GAST—Barrett's esophagus	7.76e-05	0.00142	CbGpPWpGaD
Paroxetine—SLC6A4—Circadian rythm related genes—TP53—Barrett's esophagus	7.74e-05	0.00142	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—GAST—Barrett's esophagus	7.73e-05	0.00142	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGES—Barrett's esophagus	7.67e-05	0.00141	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—GAST—Barrett's esophagus	7.66e-05	0.0014	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—SST—Barrett's esophagus	7.55e-05	0.00138	CbGpPWpGaD
Paroxetine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	7.53e-05	0.00138	CbGpPWpGaD
Paroxetine—TACR1—GPCR downstream signaling—CXCL8—Barrett's esophagus	7.37e-05	0.00135	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—GAST—Barrett's esophagus	6.8e-05	0.00125	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.76e-05	0.00124	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—CXCL8—Barrett's esophagus	6.69e-05	0.00123	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGES—Barrett's esophagus	6.6e-05	0.00121	CbGpPWpGaD
Paroxetine—CHRM2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	6.58e-05	0.00121	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—GAST—Barrett's esophagus	6.51e-05	0.00119	CbGpPWpGaD
Paroxetine—CHRM4—GPCR ligand binding—CXCL8—Barrett's esophagus	5.99e-05	0.0011	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—SST—Barrett's esophagus	5.89e-05	0.00108	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—SST—Barrett's esophagus	5.85e-05	0.00107	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—SST—Barrett's esophagus	5.84e-05	0.00107	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CYP26A1—Barrett's esophagus	5.81e-05	0.00107	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—SST—Barrett's esophagus	5.78e-05	0.00106	CbGpPWpGaD
Paroxetine—CHRM5—GPCR ligand binding—CXCL8—Barrett's esophagus	5.73e-05	0.00105	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.67e-05	0.00104	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGES—Barrett's esophagus	5.58e-05	0.00102	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—APC—Barrett's esophagus	5.37e-05	0.000984	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—SST—Barrett's esophagus	5.35e-05	0.00098	CbGpPWpGaD
Paroxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.33e-05	0.000977	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—SST—Barrett's esophagus	5.32e-05	0.000975	CbGpPWpGaD
Paroxetine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.3e-05	0.000972	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—SST—Barrett's esophagus	5.3e-05	0.000972	CbGpPWpGaD
Paroxetine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.28e-05	0.000969	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—SST—Barrett's esophagus	5.25e-05	0.000962	CbGpPWpGaD
Paroxetine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.23e-05	0.000959	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	5.13e-05	0.000941	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CYP26A1—Barrett's esophagus	5e-05	0.000916	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGES—Barrett's esophagus	4.86e-05	0.000892	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SST—Barrett's esophagus	4.66e-05	0.000854	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—TP53—Barrett's esophagus	4.64e-05	0.00085	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GAST—Barrett's esophagus	4.61e-05	0.000845	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	4.58e-05	0.00084	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GAST—Barrett's esophagus	4.58e-05	0.00084	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GAST—Barrett's esophagus	4.57e-05	0.000837	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGES—Barrett's esophagus	4.54e-05	0.000833	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GAST—Barrett's esophagus	4.52e-05	0.000829	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SST—Barrett's esophagus	4.46e-05	0.000818	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	4.23e-05	0.000776	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—RELA—Barrett's esophagus	4.19e-05	0.000769	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—SLC9A1—Barrett's esophagus	4.19e-05	0.000768	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—CXCL8—Barrett's esophagus	4.06e-05	0.000744	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	4.04e-05	0.00074	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—CXCL8—Barrett's esophagus	4.02e-05	0.000738	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—CXCL8—Barrett's esophagus	3.98e-05	0.00073	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CXCL8—Barrett's esophagus	3.95e-05	0.000725	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	3.69e-05	0.000676	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—SLC9A1—Barrett's esophagus	3.6e-05	0.000661	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	3.47e-05	0.000637	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	3.44e-05	0.000631	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.38e-05	0.00062	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.24e-05	0.000594	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SST—Barrett's esophagus	3.16e-05	0.000579	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SST—Barrett's esophagus	3.14e-05	0.000576	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SST—Barrett's esophagus	3.13e-05	0.000574	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.13e-05	0.000573	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SST—Barrett's esophagus	3.1e-05	0.000568	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—CXCL8—Barrett's esophagus	3.07e-05	0.000563	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.05e-05	0.00056	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	3.05e-05	0.000559	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—CXCL8—Barrett's esophagus	2.94e-05	0.000539	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.66e-05	0.000487	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.54e-05	0.000467	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.5e-05	0.000459	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	2.48e-05	0.000455	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—APC—Barrett's esophagus	2.46e-05	0.000452	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.46e-05	0.000451	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—Barrett's esophagus	2.43e-05	0.000445	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—APC—Barrett's esophagus	2.36e-05	0.000433	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.29e-05	0.00042	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.28e-05	0.000418	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.27e-05	0.000417	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.25e-05	0.000413	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL8—Barrett's esophagus	2.08e-05	0.000382	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.07e-05	0.00038	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL8—Barrett's esophagus	2.06e-05	0.000379	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL8—Barrett's esophagus	2.04e-05	0.000375	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2e-05	0.000367	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RELA—Barrett's esophagus	1.93e-05	0.000353	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PPARG—Barrett's esophagus	1.91e-05	0.000351	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RELA—Barrett's esophagus	1.84e-05	0.000338	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL8—Barrett's esophagus	1.81e-05	0.000333	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL8—Barrett's esophagus	1.74e-05	0.000319	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—APC—Barrett's esophagus	1.67e-05	0.000306	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—APC—Barrett's esophagus	1.66e-05	0.000305	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—APC—Barrett's esophagus	1.66e-05	0.000304	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PPARG—Barrett's esophagus	1.64e-05	0.000302	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—APC—Barrett's esophagus	1.64e-05	0.000301	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—Barrett's esophagus	1.5e-05	0.000276	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.39e-05	0.000255	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RELA—Barrett's esophagus	1.31e-05	0.000239	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RELA—Barrett's esophagus	1.3e-05	0.000238	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RELA—Barrett's esophagus	1.29e-05	0.000237	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—Barrett's esophagus	1.29e-05	0.000237	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RELA—Barrett's esophagus	1.28e-05	0.000235	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—Barrett's esophagus	1.23e-05	0.000226	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—Barrett's esophagus	1.22e-05	0.000224	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—Barrett's esophagus	1.22e-05	0.000224	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.21e-05	0.000222	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—Barrett's esophagus	1.21e-05	0.000221	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.14e-05	0.00021	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARG—Barrett's esophagus	1.13e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—Barrett's esophagus	1.11e-05	0.000204	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	1.1e-05	0.000201	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—Barrett's esophagus	1.07e-05	0.000196	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—Barrett's esophagus	9.54e-06	0.000175	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	8.99e-06	0.000165	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	8.92e-06	0.000163	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—Barrett's esophagus	7.55e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—Barrett's esophagus	7.51e-06	0.000138	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—Barrett's esophagus	7.49e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—Barrett's esophagus	7.41e-06	0.000136	CbGpPWpGaD
